Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The most recent STEP UP trial data shows even more promising results with higher-dose semaglutide ^1
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Front Endocrinol (Lausanne) 14:1161521
This trial blows both of those results out of the water
US$ 22.51
US$ 28.76
US$ 26.50
US$ 22.14
